Inhibrx Biosciences INBX
NASDAQ INBX
$104.70 +2.99 (+2.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Inhibrx Biosciences (INBX) Total Current Liabilities (2023 - 2026)

Updated

Inhibrx Biosciences' Total Current Liabilities came in at $28.06 million for Q2 2026, down 27.9% from $38.94 million a year earlier.

Analysis

Inhibrx Biosciences (INBX) Total Current Liabilities (2023 - 2026) Analysis & Trends

At the end of FY2025, Inhibrx Biosciences' Total Current Liabilities was $33.8 million, down 17.0% from FY2024.

  • Going back by year, Total Current Liabilities was $40.73 million in FY2024 (-27.7%) and $56.31 million in FY2023.
  • The Q2 2026 figure represents the lowest quarterly Total Current Liabilities in data going back to Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Inhibrx Biosciences 1.50 Bn 1.50 Bn - 28.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28.06 Mn
Dec 31, 2025 33.80 Mn
Sep 30, 2025 35.98 Mn
Jun 30, 2025 38.94 Mn
Mar 31, 2025 43.64 Mn
Dec 31, 2024 40.73 Mn
Sep 30, 2024 44.10 Mn
Jun 30, 2024 39.05 Mn
Dec 31, 2023 56.31 Mn
API Access

Inhibrx Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=INBX&period=max&api_key=YOUR_API_KEY